JELD-WEN Holding
JELD · NYSE
About JELD
- Employees
- 13,900
- Headquarters
- Charlotte, North Carolina
- Listed
- Jan 27, 2017
- Sector
- Industrials
- Industry
- Building Products
- Website
- corporate.jeldwen.com
JELD key statistics
- Market cap
- 108.45M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 1.77M
- Volume
- 1.71M
- Open price
- $1.31
- High today
- $1.35
- Low today
- $1.22
- 52 Week high
- $4.92
- 52 Week low
- $0.925
JELD-WEN Holding (JELD) at a glance
JELD-WEN Holding (JELD) last traded at $1.25, with a market cap of 108.45M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $1.22 and $1.35. The current price is 2.9% above the day's low and 7.4% below its high.
Volume so far is 1.71M shares, in line with the average of 1.77M shares a day.
Over the past year JELD-WEN Holding has ranged from $0.925 to $4.92, and now sits 8% of the way up that range.
JELD-WEN Holding met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q2 FY26 it reported -$0.11 per share against an estimate of -$0.1393.
The average analyst price target is $1.97, 57.8% above the current price, from 4 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy0.0%
- Hold100.0%
- Sell0.0%
- Low
- $1.82
- Now
- $1.25
- High
- $2.10
JELD earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 3 of the last 8 quarters, by 28.0% on average.
- Q3 FY24: reported $0.32 per share against an estimate of $0.4116
- Q4 FY24: reported -$0.10 per share against an estimate of -$0.0612
- Q1 FY25: reported -$0.17 per share against an estimate of -$0.193
- Q2 FY25: reported -$0.04 per share against an estimate of -$0.0816
- Q3 FY25: reported -$0.20 per share against an estimate of $0.1403
- Q4 FY25: reported -$0.42 per share against an estimate of -$0.2934
- Q1 FY26: reported -$0.50 per share against an estimate of -$0.2925
- Q2 FY26: reported -$0.11 per share against an estimate of -$0.1393
JELD news
- Press releasePRNewswire
- Press releasePRNewswire
JELD-WEN Announces Appointment of Interim Chief Financial Officer
- Press releasePRNewswire
JELD-WEN Announces Comprehensive Agreement to Extend Debt Maturities and Raise $135 Million of Incremental Liquidity to Support Business Plan
11 Industrials Stocks Moving In Wednesday's Intraday Session
JELD-WEN Holding Q2 2026 Earnings Call: Complete Transcript
12 Industrials Stocks Moving In Tuesday's Pre-Market Session
12 Industrials Stocks Moving In Monday's After-Market Session
- Press releasePRNewswire
JELD-WEN Reports Second Quarter 2026 Results and Updates Guidance
Similar companies
Companies in the same industry as JELD-WEN Holding
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.